OSU Genome to Drug Discovery Group (GDDG) is a consortium of investigators at OSU whose interests and research focuses are in genome-based drug discovery, which includes genomics, proteomics, and metabolomics of bioactive natural products and drug targets, as well as computational and synthetic-based drug design.
